Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Oaktree Acquisition Corp. II
OACC ยท SEC Filings
website
3
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuse...
Price
10.71
Market Cap
263.28 M
Float
19.2 M
Country
US
Sector
Financial Services
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about OACC
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Oaktree Acquisition Corp. II
OACC ยท SEC Filings
19.2 M
Float
10.71
Price
263.28 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Oaktree Acquisition Corp. III Life Sciences Announces Share Conversion and Business Combination Extension Approval
Oct 26, 2026
8-K
Oaktree Acquisition Corp. III Life Sciences Postpones General Meeting to October 23, 2026
Oct 16, 2026
8-K
Oaktree Acquisition Corp. III Life Sciences Announces Preliminary Redemption Results and Sponsor Share Conversion
Oct 15, 2026
8-K
Oaktree Acquisition Corp. III Life Sciences Announces CFO Resignation and Appointment
Oct 29, 2025
8-K
Oaktree Acquisition Corp. III Life Sciences Appoints Dr. David A. Berry as Independent Director
Oct 17, 2025
8-K
Oaktree Acquisition Corp. III Life Sciences Announces CFO Resignation and Appointment
Jun 6, 2025
Prospectus
TYPE
HEADLINE
FILED AT
424B4
OFFERING | Shares amount: 17,500,000 | Share price: $10.00 | Warrants amount: 3,500,000 | Warrants exercise price: $11.50 | Offering amount: $175,000,000.00
Oct 24, 2024
Registrations
TYPE
HEADLINE
FILED AT
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 16, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 15, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Oct 2, 2026
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Sep 21, 2026
Ownerships
TYPE
HEADLINE
FILED AT
4
OAKTREE CAPITAL MANAGEMENT LP (Reporting)
Oct 23, 2026
SCHEDULE 13G
Decagon Asset Management LLP (Filed by)
Aug 14, 2026
SCHEDULE 13G
BARCLAYS PLC (Filed by)
Aug 13, 2026
SCHEDULE 13G
Fort Baker Capital Management LP (Filed by)
May 15, 2026
SCHEDULE 13G
GOLDMAN SACHS GROUP INC (Filed by)
May 11, 2026
SCHEDULE 13G/A
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Feb 11, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Oct 24, 2024
CORRESP
Form CORRESP - Correspondence
Oct 21, 2024
CORRESP
Form CORRESP - Correspondence
Oct 21, 2024
CORRESP
Form CORRESP - Correspondence
Oct 18, 2024
LETTER
Form UPLOAD - SEC-generated letter
Oct 18, 2024
CORRESP
Form CORRESP - Correspondence
Oct 4, 2024